Humedix Co., Ltd. (200670.KQ)

KRW 42800.0

(3.38%)

Operating Expenses Summary of Humedix Co., Ltd.

Humedix Co., Ltd.'s latest annual operating expenses in 2023 was 33.04 Billion KRW , up 11.56% from previous year.
Humedix Co., Ltd.'s latest quarterly operating expenses in 2024 Q1 was 7.42 Billion KRW , down -26.59% from previous quarter.
Humedix Co., Ltd. reported a annual operating expenses of 27.8 Billion KRW in annual operating expenses 2022, up 4.1% from previous year.
Humedix Co., Ltd. reported a annual operating expenses of 26.71 Billion KRW in annual operating expenses 2021, up 23.68% from previous year.
Humedix Co., Ltd. reported a quarterly operating expenses of 9.28 Billion KRW for 2024 Q2, up 25.09% from previous quarter.
Humedix Co., Ltd. reported a quarterly operating expenses of 7.12 Billion KRW for 2023 Q1, up 1.08% from previous quarter.

Annual Operating Expenses Chart of Humedix Co., Ltd. (2023 - 2015)

Historical Annual Operating Expenses of Humedix Co., Ltd. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	33.04 Billion KRW	11.56%
2022	27.8 Billion KRW	4.1%
2021	26.71 Billion KRW	23.68%
2020	21.6 Billion KRW	15.01%
2019	18.78 Billion KRW	30.45%
2018	14.39 Billion KRW	16.68%
2017	12.33 Billion KRW	30.96%
2016	9.42 Billion KRW	121850.88%
2015	7.72 Million KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	7.42 Billion KRW	-26.59%
2024 Q2	9.28 Billion KRW	25.09%
2023 Q1	7.12 Billion KRW	1.08%
2023 Q4	10.11 Billion KRW	30.51%
2023 FY	31.02 Billion KRW	11.56%
2023 Q3	7.75 Billion KRW	9.04%
2023 Q2	7.1 Billion KRW	-0.2%
2022 Q1	6.87 Billion KRW	-16.75%
2022 Q4	7.04 Billion KRW	2.78%
2022 FY	27.8 Billion KRW	4.1%
2022 Q3	6.85 Billion KRW	30.18%
2022 Q2	5.26 Billion KRW	-23.36%
2021 Q3	6.6 Billion KRW	-2.82%
2021 Q1	6.26 Million KRW	-10.48%
2021 Q2	6.79 Billion KRW	108337.44%
2021 Q4	8.25 Billion KRW	25.0%
2021 FY	26.71 Billion KRW	23.68%
2020 Q1	5.5 Million KRW	-14.28%
2020 FY	21.6 Billion KRW	15.01%
2020 Q4	7 Million KRW	98.16%
2020 Q3	3.53 Million KRW	8.2%
2020 Q2	3.26 Million KRW	-40.72%
2019 Q3	4.68 Million KRW	-7.53%
2019 Q2	5.07 Million KRW	33.05%
2019 Q1	3.81 Million KRW	-28.4%
2019 FY	18.78 Billion KRW	30.45%
2019 Q4	6.42 Million KRW	37.0%
2018 Q4	5.32 Million KRW	76.75%
2018 FY	14.39 Billion KRW	16.68%
2018 Q1	3.02 Million KRW	-21.96%
2018 Q2	2.84 Million KRW	-6.08%
2018 Q3	3.01 Million KRW	6.01%
2017 Q2	722.87 Thousand KRW	-75.36%
2017 FY	12.33 Billion KRW	30.96%
2017 Q1	2.93 Million KRW	-41.46%
2017 Q4	3.87 Million KRW	57.52%
2017 Q3	2.46 Million KRW	240.41%
2016 Q2	1.89 Million KRW	24.36%
2016 Q1	1.52 Million KRW	0.0%
2016 FY	9.42 Billion KRW	121850.88%
2016 Q3	2.49 Million KRW	31.85%
2016 Q4	5.01 Million KRW	101.02%
2015 FY	7.72 Million KRW	0.0%

Peer Operating Expenses Comparison of Humedix Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
HLB Pharmaceutical Co., Ltd	102.52 Billion KRW	67.771%
CMG Pharmaceutical Co., Ltd.	37.86 Billion KRW	12.737%
Celltrion Pharm, Inc.	80.93 Billion KRW	59.173%
Huons Global Co., Ltd.	294.87 Billion KRW	88.794%
DongKook Pharmaceutical Co., Ltd.	338.16 Billion KRW	90.229%
Enzychem Lifesciences Corporation	18.7 Billion KRW	-76.663%
Boditech Med Inc.	47.05 Billion KRW	29.772%
EuBiologics Co., Ltd.	24.95 Billion KRW	-32.386%
FutureChem Co.,Ltd	9.16 Billion KRW	-260.495%
Huons Co., Ltd.	226.14 Billion KRW	85.388%
BNC Korea Co., Ltd.	25.19 Billion KRW	-31.131%
AptaBio Therapeutics Inc.	16.45 Billion KRW	-100.848%